Can asset‐backed securitisation reduce corporate leverage? Evidence from China
Accounting & Finance · 2024-12 · 64 (4) · 3337-3359
DOI: 10.1111/acfi.13254 ↗Kurz gefasst
Fachartikel in der Zeitschrift Accounting & Finance, online erschienen am 25.03.2024. Verfasst von Ronghui Pang und 3 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Natural Science Foundation of Shandong Province, Chinese National Funding of Social Sciences.
Abstract (Originalsprache)
Although Chinese regulatory authorities view corporate asset‐backed securitisation as a powerful tool for deleveraging, its effectiveness remains unexamined. Employing a look‐through approach to data from nonfinancial corporate asset‐backed securitisation transactions in China, we identify the actual originators and examine the impact of corporate asset‐backed securitisation on their leverage ratios. Regrettably, we find that corporate asset‐backed securitisation significantly increases the leverage ratio. This result holds true across both state‐owned and non‐state‐owned enterprises, as well as large‐scale and small‐scale enterprises. Finally, this study reveals that the effect of corporate asset‐backed securitisation on the leverage ratio is partially mediated by internal financing capacity.
Förderung
- Natural Science Foundation of Shandong Province
- Chinese National Funding of Social Sciences
Zitieren
APA
Pang, R., Zhang, Y., Li, J., & Xie, S. (2024). Can asset‐backed securitisation reduce corporate leverage? Evidence from China. Accounting & Finance, 64(4), 3337-3359. https://doi.org/10.1111/acfi.13254
Vancouver
Pang R, Zhang Y, Li J, Xie S. Can asset‐backed securitisation reduce corporate leverage? Evidence from China. Accounting & Finance. 2024;64(4):3337-3359. doi:10.1111/acfi.13254
BibTeX
@article{Pang2024,
author = {Pang, Ronghui and Zhang, Yanan and Li, Jianbiao and Xie, Shaopeng},
title = {Can asset‐backed securitisation reduce corporate leverage? Evidence from China},
journal = {Accounting & Finance},
year = {2024},
volume = {64},
number = {4},
pages = {3337--3359},
doi = {10.1111/acfi.13254}
}
EUVIMED